Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-008102

CEO sold 12,194 shares at $19.06 ($232,418)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-17 Sale : show line 1 in the form −12,194 $19.06 $232,418 536,885 D
Open-market sales · 12,194 sh · avg $19.06 · $232,418
Loading xslF345X03/form4.xml…